⌘K

Login Start Free

Home/Filings/4/0001209191-24-001198

4//SEC Filing

Virsik Peter 4

Accession 0001209191-24-001198

CIK 0001633932other

View on SEC.gov Company Profile

Filed

Jan 7, 7:00 PM ET

Accepted

Jan 8, 8:06 PM ET

Size

4.8 KB

Accession

0001209191-24-001198

Insider Transaction Report

Form 4

Period: 2024-01-05

ESSA Pharma Inc.EPIX

Chief Operating Officer

Transactions

Sale
Common Shares
2024-01-05$6.11/sh−699$4,271→ 14,022 total

Footnotes (1)

[F1]The amount reflects the sale of shares pursuant to Mr. Virsik's 10b5-1 trading plan. The Rule 10b5-1 trading plan was entered into on August 31, 2023.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

ESSA Pharma Inc.

CIK 0001633932

Entity typeother

Related Parties

1

filerCIK 0001826322

Filing Metadata

Form type: 4
Filed: Jan 7, 7:00 PM ET
Accepted: Jan 8, 8:06 PM ET
Size: 4.8 KB

View on SEC.gov